High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection.
about
Management of pre-invasive disease of the cervix.Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growthPostmodern cancer: the role of human immunodeficiency virus in uterine cervical cancerPathogenesis of genital HPV infection.Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.Cervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort.The clinical manifestations and treatment of sexually transmitted diseases in human immunodeficiency virus-positive men.Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females.HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosisAdolescent behavior and sexually transmitted diseases: the dilemma of human papillomavirus.Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe.Smoking and cervical cancer.Therapeutic approaches to AIDS-related malignancies.Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals.A study of anal intraepithelial neoplasia in HIV positive homosexual men.A matched prospective study of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopyHuman Immunodeficiency Virus Localization in Human Papillomavirus-Related, High-Grade Squamous Intraepithelial Lesions of the Cervix in Women with HIV Infection: Microdissection and Molecular Analysis on Formalin-Fixed and Paraffin-Embedded SpecimenRole of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated cervical neoplasia.Detection of human herpesvirus 6 and human papillomavirus 16 in cervical carcinoma.Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings.Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia.Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasiaLangerhans cell density and high-grade vulvar intraepithelial neoplasia in women with human immunodeficiency virus infection.The prevalence of cervical cytology abnormalities and human papillomavirus in women infected with the human immunodeficiency virusFrom human papillomavirus (HPV) to cervical cancer: psychosocial processes in infection, detection, and control.Malignancies in women with HIV infection.Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women.Cervical cytological screening in HIV-infected women in Dublin--a six-year review.Women and AIDS.Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV.Genital types of papillomavirus in children of women with HIV-1 infection in Kinshasa, Zaire.Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.Incidence of cervical human papillomavirus infection in systemic lupus erythematosus women.Clinical aspects of HIV infection in women.HIV-related tumors of the oral cavity.The 1993 Okey Memorial Lecture. Cross-national studies of AIDS among injecting drug users.The epidemiology of cervical carcinogenesis.Update on human papillomavirus.Enhancement of TAT-induced transactivation of the HIV-1 LTR by two genomic fragments of HHV-6.
P2860
Q30630872-82205D73-6CBC-4DB1-BE96-3D39A28CF6F0Q33604559-213AF593-1594-47E4-BAB8-C7F9330D0536Q33918893-5E88B2C1-FA3E-40F1-A7DC-421385B502FEQ33934353-82178B3B-6FCB-4A4E-A8C2-3B2575241F68Q34030477-004DDF7F-23A1-42E0-8E53-8BB178CC4206Q34124803-44F87D9D-774C-4D1D-B10C-F00F54958C03Q34142034-23EF03A9-9752-42D4-8540-37CCD7BF540BQ34146342-C2B1BFDC-FD74-423F-A4DD-E64FD871DB5FQ34466134-AA38B32F-35E7-484F-9ADA-9892D3346AB0Q34633135-1F6F21AA-32DC-4A9C-8C4E-804FF364D458Q34743282-7F9B0406-4C88-43C0-B0F3-290E9BB69933Q35116969-C41BD32F-7E77-413D-833D-0A3B0A64AFEBQ35551167-02EEF109-3F29-4B41-8405-69FE68927251Q35562273-D3795234-DC60-41A1-B29E-E9EBFFB63BA9Q35562494-E73F53F3-3E7F-4D32-A81D-C4A3120DB69EQ35615224-575844A8-0FBC-4B74-9CCD-467B7884E973Q35624093-139B4F27-AF5B-4693-ADAB-6088496F6C76Q35833443-2C1739E7-1CE3-40DC-8198-41DD5E588FD7Q35834205-8B459260-1681-4D51-8FB7-F743D3CA7B27Q35884800-5F89E762-A728-4086-B20D-BFA247291ED8Q36610462-B37CBECB-E473-475E-BBED-91BD89CBA7F3Q36677490-009B829C-4E65-450F-A8E9-F7FCF79A6942Q36852164-6AC6954D-A00D-4E3A-A02D-6C26FB9B90FDQ37089491-387FFA22-C7E4-4357-B71F-F8EFFBD0D4A7Q37143294-B3121078-782E-4A35-8D3E-9703EBA4F0F2Q37346149-5D53379C-FB04-401A-8E7F-7452B81D0F7BQ37357672-13333402-FEBE-4B94-AB80-70A4CB620503Q39155061-3C7A838E-4AD4-453A-9975-4AA08D851F6FQ39371452-C84B37F4-86D1-4566-9225-ACC39333D173Q39440269-9D522735-5C9B-4985-8615-2B65323897DFQ39443055-374F5D1F-416C-40BA-B5BC-44C627055A68Q39485420-30008C8E-3CAA-471E-9466-298698B5267AQ39517653-E6ECE8C1-48D5-4AE8-A9D4-6CC4F6D49E1FQ40383158-EA766CAE-E8B3-4D1B-A5FC-87569A4A9463Q40513971-27C2DBA7-E6F2-423F-92FA-A90CC84D7008Q40594282-0D852A87-6ED6-4CA2-961B-5353F6FB2D59Q40668679-AA20E187-5D75-4D15-A309-C013132D0F7DQ40989058-DE2E7F1E-64E5-484C-B485-992ADB808480Q41024687-FD1D0DC0-DCEB-4494-A011-B383F31204D2Q41170197-F077B74C-293B-4879-93F5-A6B30F8B5CA7
P2860
High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
High risk of human papillomavi ...... unodeficiency virus infection.
@en
High risk of human papillomavi ...... unodeficiency virus infection.
@nl
type
label
High risk of human papillomavi ...... unodeficiency virus infection.
@en
High risk of human papillomavi ...... unodeficiency virus infection.
@nl
prefLabel
High risk of human papillomavi ...... unodeficiency virus infection.
@en
High risk of human papillomavi ...... unodeficiency virus infection.
@nl
P2093
P1476
High risk of human papillomavi ...... unodeficiency virus infection.
@en
P2093
P304
P356
10.1016/0002-9378(91)90101-V
P407
P50
P577
1991-08-01T00:00:00Z